Close
ACHEMA MIDDLE EAST 2026

Synaffix Inks $586m Deal with MacroGenics to Enable Next Generation ADCs

Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, announces...

Nanoform signs GMP manufacturing program with TargTex following formulation success

Nanoform, an innovative nanoparticle medicine enabling company, announced it has signed a GMP1 manufacturing program (clinical development) to enhance TargTex’s Glioblastoma multiforme drug candidate....

PCI Pharma Services Continues to Expand Sterile Fill-Finish Expertise with State-of-the-Art Equipment

PCI Pharma Services is pleased to announce the addition of three new exceptional automated sterile fill-finish machines in our San Diego and Melbourne facilities....

GSK Drug Cabenuva with two month dosing gets the FDA Nod

Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was regarded as a peerless...

Gilead To Shell $1.25B On GSK Patent Settlement For Biktarvy

It doesn’t come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are fighting out in  HIV domain for a long time,...

Bharat Biotech To Soon Foray Into Nasal Covid-19 Vaccine

Bharat Biotech has been granted permission by India’s drug controller to execute standalone phase 3 clinical trials on the intranasal vaccine for COVID-19. Besides...

Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Australia's Therapeutic Goods Administration (TGA) has...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...